Cargando…

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance

BACKGROUND: Contrast enhanced magnetic resonance imaging (MRI) is an important tool for the assessment of extracardiac vasculature and myocardial viability. Gadolinium (Gd) brain deposition after contrast enhanced MRI has recently been described and resulted in a warning issued by the United States...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaki, Neil, Parra, David, Wells, Quinn, Chew, Joshua D., George-Durrett, Kristen, Pruthi, Sumit, Soslow, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713146/ https://www.ncbi.nlm.nih.gov/pubmed/33267835 http://dx.doi.org/10.1186/s12968-020-00676-2

Ejemplares similares

Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
por: Raucci, Frank J., et al.
Publicado: (2021)

Reference data for left ventricular filling and atrial function in children using cardiovascular magnetic resonance
por: Henderson, Christopher C., et al.
Publicado: (2023)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain
por: Taoka, Toshiaki, et al.
Publicado: (2018)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Association of cardiovascular magnetic resonance diastolic indices with arrhythmia in repaired Tetralogy of Fallot
por: Kikano, Sandra D., et al.
Publicado: (2023)

Gadolinium contrast agents: dermal deposits and potential effects on epidermal small nerve fibers
por: Krämer, Heidrun H., et al.
Publicado: (2023)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance
por: Hedström, Erik, et al.
Publicado: (2010)

Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
por: Rees, Julian A., et al.
Publicado: (2018)

Nonlinear self-calibrated phase contrast correction in pediatric and congenital cardiovascular magnetic resonance imaging
por: Paul, Erin A, et al.
Publicado: (2016)

Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
por: Meng, Howard, et al.
Publicado: (2012)

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
por: Ghaghada, Ketan B., et al.
Publicado: (2009)

Gadolinium Deposition in the Brain: Current Updates
por: Choi, Jin Woo, et al.
Publicado: (2019)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Fatal Allergic Reaction to Gadolinium Contrast
por: Chalise, Som N, et al.
Publicado: (2023)

Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement
por: Swanson, Scott D, et al.
Publicado: (2008)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review
por: Al-Muhanna, Afnan Fahd
Publicado: (2022)

Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
por: Sunthankar, Sudeep D., et al.
Publicado: (2023)

Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement
por: Soslow, Jonathan H, et al.
Publicado: (2016)

Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents
por: Hojreh, Azadeh, et al.
Publicado: (2020)

Motion-corrected free-breathing late gadolinium enhancement combined with a gadolinium contrast agent with a high relaxation rate: an optimized cardiovascular magnetic resonance examination protocol
por: Yan, Cui, et al.
Publicado: (2020)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
por: Clough, Thomas J., et al.
Publicado: (2019)

The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T(1) relaxometry in patients with prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2020)

Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients
por: Kühn, Isabelle, et al.
Publicado: (2021)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Baseline correction of phase-contrast images in congenital cardiovascular magnetic resonance
por: Holland, Brian J, et al.
Publicado: (2010)

COVID-19 Myocardial Pathology Evaluated Through scrEening Cardiac Magnetic Resonance (COMPETE CMR)
por: Clark, Daniel E., et al.
Publicado: (2020)

The dynamics of extracellular gadolinium-based contrast agent excretion into pleural and pericardial effusions quantified by T1 mapping cardiovascular magnetic resonance
por: Thalén, Simon, et al.
Publicado: (2019)

Characteristics of COVID-19 Myocarditis With and Without Multisystem Inflammatory Syndrome
por: Li, Dan Leslie, et al.
Publicado: (2022)

Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC)
por: Clark, Daniel E., et al.
Publicado: (2021)

Concurrent Dual Contrast for Cellular Magnetic Resonance Imaging Using Gadolinium Oxide and Iron Oxide Nanoparticles
por: Loai, Yasir, et al.
Publicado: (2012)

Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease
por: Kollar, Sarah E., et al.
Publicado: (2022)

Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients
por: Lee, Ji Ye, et al.
Publicado: (2017)

The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposure
por: DeAguero, Joshua, et al.
Publicado: (2023)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lhq918nave4rsrhq07src90a19